Interferons (IFN) are cytokines released from animal cells in response to virus infection
or to a variety of other stimuli. By binding to specific cell surface receptors IFN exerts a wide range of functions, including inhibition of virus multiplication (1, 2) . The varying effects of IFN are mediated by more than 30 different proteins which are induced after IFN treatment of the cells (1) (2) (3) and only the role of a few of them in the antiviral state is beginning to be elucidated.
The best characterized IFN-induced proteins are the Mx family of proteins, the two doublestranded (ds) RNA-dependent enzymes, a 68 kDa protein kinase (PKR) and 2-5A-synthetase, and the 2-5A-dependent RNase (RNase L) (3, 4) . The proteins 2-5A-synthetase and RNase L constitute, together with 2-5A-phosphodiesterase, what is known as 2-5A pathway or 2-5A system, an IFN regulated RNA degradative pathway (5) . Although basal levels of these proteins are found in most, if not all, mammalian cells, treatment with IFN induces at least four different forms of 2-5A-synthetase and a unique RNase L (reviewed in reference 3). Double-stranded RNA activates the 2-5A-synthetases that, in the presence of ATP, synthesize a complex mixture (referred to as 2-5A) of 5'-triphosphorylated oligoadenylic acid, ppp(A2'p5)nA, that binds to and activates endoribonuclease RNase L (2). Activated 2-5A-dependent RNase L cleaves viral and cellular RNAs, with the result of general inhibition of protein synthesis (2) .
Characterization of the biological role of the 2-5A system has advanced by cloning of murine and human RNase L genes (6) which encode proteins of very interesting molecular architecture (7, 8) . Human RNase L (83.5 kDa) contains 9 ankyrin-like repeats at the N terminus which are immediately followed by a complete protein kinase domain and next to it, in the C terminus, the residues where the endoribonuclease activity is located. Ankyrin repeats have been involved in mediating intra-and intermolecular protein-protein interactions in many different types of proteins (9) . Systematic biochemical studies of IFN-treated virus-infected cells has only revealed the 2-5A system as responsible for virus inhibition in the case of picornaviridae. Direct evidence for antiviral activity of this pathway was shown by constitutive expression of a cDNA encoding human 40 kDa 2-5A-synthetase (10) (11) (12) . The inhibitory effect is selective for mengovirus and encephalomyocarditis (EMC) virus with little effect on either vesicular stomatitis virus (VSV) or herpes simplex 2 (HSV-2) (10) (11) (12) . Inhibition of picornaviridae by IFN 4 also requires functional RNase L as has been demonstrated in a stable cell line expressing high levels of a truncated RNase L which is a dominant negative mutant of this enzyme (7) . However, the contribution of the 2-5A system to the antiviral activities of IFN almost certainly goes beyond the picornaviridae family of viruses and is obscured by virus-induced IFN-resistance mechanisms (reviewed in references 2 and 3). There is evidence suggesting that this is probably the case for vaccinia virus (VV), a poxvirus which replicates in the cytoplasm of a wide range of cells, and that has been found to be resistant to IFN in many cultured cell lines (13, 14) while sensitive in others (15) and in experimental animals (16) . The reason for the differential sensitivity of VV to IFN in vivo and in vitro might be related to the ability of the virus to synthesize interfering products. Indeed, VV displays an impressive variety of defensive strategies to evade the host response to infection, including counteraction of IFN by strategies at two different levels (reviewed in reference 17): production of soluble type I and II IFN receptors which blocks IFN action at a very early stage (18, 19) and modulation of the activity of the IFNinduced proteins. The product of ORF E3L competitively binds ds RNA and prevents the activation of the IFN-induced ds RNA-activated PKR (20) and probably also 2-5A-synthetase (21) . Down regulation of the activation of p68 kinase is also attained by the product of ORF K3L, a protein with sequence similarity to eukaryotic initiation factor 2 (eIF2 ), that competitively binds PKR and therefore blocks inactivation by phosphorylation of eIF2 (22) .
Besides these proteins, there are results suggesting that VV uses additional mechanisms to evade IFN action. The product of ORF A18R, a mediator in virus RNA metabolism (23) , and NPH-I, an enzyme involved in virus transcription (24) , could be modulating the 2-5A system but if this happens by a direct or indirect mechanism remains to be determined. Finally, there are also results suggesting VV induced ATPase and phosphatase activities being involved in viral interference with the 2-5A system (25, 26) .
In this investigation we have examined whether the IFN-induced enzymes 2-5A-synthetase and 2-5A-dependent RNase L could be responsible for inhibition of VV replication in situations of virus sensitivity to IFN. To this aim we have generated VV recombinants able to express individually each one of the IFN-induced enzymes in the 2-5A pathway and analyzed the effect of their expression in VV replication using a cell line where the virus is otherwise mainly 5 resistant to IFN action. A recombinant virus where expression of RNase L can be regulated was obtained by cloning of the human gene, contained in plasmid ZC-5 (6), under the control of the bacteriophage T7 promoter into VV insertion vector pTM1-E (27) (Fig.1A) . We first generated plasmid pPR35-RL by insertion of a Hind III fragment of ZC-5 into the Sma I site of pPR35 (28) . Plasmid pRSET-RL for expression in E.coli was then obtained by cloning of a Pst I + Kpn I fragment of pPR35-RL into pRSET-B digested in the same way. It contains the coding sequence for RNase L, lacking only nucleotides coding for the 21 amino acids at the N terminus, fused to a sequence for 38 new amino acids that includes a stretch of 6 histidine residues and the 11 amino acid gene 10 leader peptide. We also generated plasmid pRSET-∆N by Nco I digestion of pRSET-RL and religation. This plasmid is similar to pRSET-RL but lacking sequences coding for amino acids 228 to 741 of RNase L. Insertion plasmids pTM-RL and pTM-∆N were then obtained by cloning DNA fragments from plasmids pRSET-RL (Nde I) and pRSET-∆N (Nde I + Nco I), respectively, into the Sma I site of VV insertion vector pTM1-E (27) and they contain 8 extra amino acids in the N terminus in front of the initiation codon provided by pRSET-B. Recombinant viruses VV-RL and VV-N were generated by homologous recombination of plasmids pTM-RL and pTM-∆N into thymidine kinase (tk) gene of wild type vaccinia virus (WR) and selection in human TK -143B cells with 5'-bromodeoxyuridine (25 g/ml) basically as described (29) . Two rounds of plaque purification yielded homogeneous virus preparations containing the desired genes, as confirmed by Southern blot DNA hybridization analysis (data not shown). We also prepared a rabbit polyclonal antiRNase L serum able to recognize proteins produced by these recombinant viruses, using the C-terminus of this protein (amino acids 340 to 741) expressed in E.coli as the antigen.
Exponentially growing E.coli BL21 (DE3) cells carrying plasmid pRSET-∆2S, generated by Late during VV infection of cells in culture, concomitant with synthesis of complementary mRNAs due to symmetrical transcription of late genes, 2-5A is produced at high levels (14, 26) and although is biologically active when assayed in vitro is not able to inhibit VV replication in cultured cells (14) . The resistance of VV to the 2-5A system is probably due to the existence of viral products that directly or indirectly counteract the activation of endogenous RNase L. The levels of activatable RNase L and of 2-5A might be critical in the sensitivity / resistance phenomenon of VV to the 2-5A system. To address this hypothesis, we measured 
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We next examined if by increasing the levels of 2-5A through expression of 2-5A-synthetase in combination with RNase L, further enhances the inhibition of VV protein synthesis and what is the net effect in viral replication. To this aim we generated VV recombinant VV-2-5AS where expression of human 40-kDa 2-5A-synthetase is driven by the virus constitutive early-late promoter p7.5. The recombinant was obtained by homologous recombination of plasmid pSC-2-5AS into wild type virus (WR) thymidine kinase (tk) gene basically as described (29) . The DNA was obtained by cloning of a 1.2 kb fragment from plasmid pTL4-2-5AS (Nco I + Xho I digested and ends filled with Klenow fragment) into the Sma I site of VV insertion vector pSC 11 (34) . It contains the complete human 40-kDa 2-5A-synthetase coding sequence lacking methionine residue in the N terminus and the E.coli ß-galactosidase gene (lac z ) under the control of a late viral promoter (p11). Recombinant viruses were selected in human TK -143B cells using X gal and 5'-bromodeoxyuridine (25 g/ml) (29) (Fig. 3A, upper panel, lane VV-(IBT)). This is an anti-poxviral drug which causes a significant increase in the amount of ds RNA synthesized during VV infection, therefore inducing cleavage of rRNA with a pattern that is the characteristic one for activation of the 2-5A pathway (36) . The levels of recombinant proteins RNase L and 2-5A-synthetase were analyzed by using specific rabbit polyclonal sera and the results obtained at 48h of infection are presented in Fig. 3B . Cleavage of rRNA correlates in all cases with expression of RNase L and / or 2-5A-synthetase (compare lower panel in Fig. 3A and Fig. 3B ). Samples presenting the highest levels of rRNA degradation also show clear signs of protein synthesis inhibition with amounts of RNase L and 2-5A-synthetase being, respectively, moderate and severely inhibited. Analysis of de novo virus protein synthesis at 24h of infection (Fig. 3C) showed very low levels of protein synthesis activity in cells infected with vT7 + VV-RL that are further reduced by co-expression of 2-5A-synthetase (compare lanes 5 and 7).
The effect of expression of enzymes in the 2-5A pathway on virus yields is shown in Table 1 . Production of infectious virus at 24 and 48h was quantitated by plaque assay and values referred to results obtained for cell infected with VV-RL in the absence of vT7. Expression of 2-5A-synthetase by itself causes inhibition of virus replication by 60 and 77.5 % at 24h and 48h of infection, respectively. Expression of RNase L inhibits virus yields by 75 and 92.1 % at 24 and 48h of infection, respectively, while combined expression of RNase L and 2-5A-synthetase enhances the inhibition of virus growth to 96.6 % at 48h. Reduction in virus yields due to RNase L expression is a late event and it is only apparent after 12h of infection (data not shown). The limited reduction in viral yields observed in these experiments is probably due to the kinetics of RNase L activation. Synthesis of this protein is detected for the first time 14 h after infection (Fig. 2A, lane 4) and inhibition of protein synthesis is clearly observed starting at about the same time (Fig. 2C, lane 3) , a relatively late time point in VV infection when most viral protein synthesis has already occurred.Therefore, the one log reduction observed in our expression system probably is an underestimate of the potency of the 2-5A system in VV sensitivity to IFN.
In order to establish that inhibition of VV replication is specific, we have also analyzed the effect of RNase L expression in the replication of vesicular stomatitis virus (VSV) which is very sensitive to IFN treatment, although has been previously described as resistant to the 2-5A system (12) (data not shown), has no effect on VSV replication as indicated in Table 2 .
We have also investigated if RNase L is the only protein responsible for the effects To exclude this possibility, we have infected mouse 3T3-like cell lines derived from homozygous PKR knockout mice (Pkr 0/0 ) or wild type animals (Pkr +/+ ) (37) (Fig. 4B) .
Absence of murine 65 kDa protein kinase in the cell line derived from Pkr 0/0 mice is shown by immunoblot of protein extracts using a rabbit polyclonal antiserum specific for mouse PKR (left panel, Fig. 4B ). De novo protein synthesis activity was then measured in mock-infected cells or in cells infected for the indicated times with vT7 + VV-RL or vT7 + VV-N (m.o.i. 10 each virus) by pulse-labeling with 35 S-methionine + cysteine as described (Fig. 4B, right panels) . RNase L is a low abundance protein which is increased from 2 to 10 fold in some cells after treatment with IFN (38) . On the contrary, the amount of 2-5A-synthetase usually increases substantially in response to IFN (10 to 10,000-fold) although the high levels of 2-5A-synthetase produced in cells transfected with the 40-kDa 2-5A-synthetase human gene are not sufficient by themselves to protect against picornaviruses, and minimum levels of RNase L are also required (39) . These data can be interpreted to mean that the antiviral state in the cell is compatible with amounts of 2-5A-synthetase in a very broad range while small changes in levels of activated RNase L are really critical. Our results, obtained in cells infected with the recombinant viruses, provide evidence for this hypothesis and showed that expression of RNase L by itself causes greater inhibition of VV replication than expression of 2-5A-synthetase (Table 1) . Because there is endogenous RNase L in the cells used in these experiments, we have tried to separate the contribution of endogenous and recombinant enzymes by using stable cell line SVT2/ZB1.4 expressing a dominant negative mutant of RNase L (7). However, infection of these cells with vT7 + VV-RL produced degradation of rRNA similar to control cells SVT2/pSVL. A possible explanation is that levels of mutant RNase L, which has been described as insufficient to counteract the anti-EMCV effect of IFN (7), are also below the amounts of RNase L produced by vT7+VV-RL infection. The VV cell system described here for expression of enzymes in the 2-5A pathway has two main advantages: first, it makes possible to increase the levels of these enzymes in a controlled fashion, and second, virus infection provides at the same time a very powerful activator of the system, i.e. ds RNA, a byproduct of virus replication. We believe that RNase L activation requires first of all production of the protein and then synthesis of ds RNA, the activator of endogenous 2-5A-synthetase that produces 2-5A oligonucleotides at late times of infection (14, 25, 26) . We have previously described that 2-5A levels in untreated BSC-40 cells are 1.4 nM by 8h of infection with VV and increase to 3.0 nM by 24h of infection (26) . Low concentrations of 2-5A (≤ 1nM) are normally required to activate the 2-5A-dependent RNase in vitro (14) and 2-5A extracted from VV infected cells is biologically active when assayed in vitro (14) . Because degradation of RNA occurs during infection with VV-RL, our results strongly suggest that 2-5A accumulated in infected cells is also biologically active in vivo. Then, how can we explain that 2-5A produced during wild type VV infection of BSC-40 cells does not induce rRNA breakdown?. We propose the existence of a mechanism directly responsible of interference with 2-5A-dependent RNase L. Therefore, during infection of cells with the recombinant virus expressing RNase L, activation of this enzyme would be fulfilled only when enough levels of RNase L and its specific activator dsRNA accumulate as to out-number viralinduced resistance mechanisms specific for this enzyme. Indeed, induced expression of PKR with a recombinant VV similar to VV-RL has been shown to counteract viral mechanisms of interference with this pathway and cause inhibition of its own replication (40) . We envisage 13 resistance or sensitivity of VV to IFN as a tightly regulated equilibrium between levels of the IFN-induceable proteins (basal, IFN-induced or recombinant virus-induced enzymes in our expression system), their activators, such as ds RNA and 2-5A provided upon viral infection, and virus-encoded resistance products. Subtle changes in the levels of some of the components in the 2-5A system can direct the cell toward an IFN sensitive or resistant phenotype that might also explain differences in IFN sensitivity found for VV infecting different cell lines (13) (14) (15) .
Levels of inhibition of virus protein synthesis by
Although in our expression system several positive or negative regulatory factors are involved, maintaining the multiplicity of infection equal in each experiment with auxiliary recombinant tk(-) viruses warranties the same contribution of all these factors. Therefore, effects observed can be specifically attributed to expression of the recombinant proteins.
In conclusion, in this report we provide direct evidence with cultured cells that by increasing the levels of enzymes in the 2-5A pathway we generate an antiviral state in the cell that is effective upon VV replication but does not affect VSV, which has been previously shown to be insensitive to this pathway. Since replication of VV is severely inhibited in IFN-treated animals, the biological significance of our findings is to point out that in vivo the 2-5A system is likely to be a mediator of the anti-poxvirus action of IFN and that modulation of the 2-5A pathway might have therapeutic value. The unique system described here provides the means to search for virus interference factors throughout their interaction with RNase L. In addition, by expressing mutant or truncated forms of enzymes in the 2-5A system, it should be possible to define in vivo functional domains in these important proteins. 
